From: Obesity: An overview on its current perspectives and treatment options
Drugs in phase II trials | Drugs in phase III trials |
---|---|
Bupropion (dopamine reuptake inhibitor) | Mazindol (adrenergic agonist) |
Linitript (cholecystokinin A antagonist) | Sertraline (selective serotonin uptake inhibitor) |
Pegylated leptin | Posatirelin (thyrotrphin-releasing hormone analogue) |
Dipeptidyl peptidase IV inhibitors | Cannabinoid antagonists |
Human growth hormone factor AOD9604 | Lipase inhibitor, ATL-962 |
Phytostanol | Â |